Ellagic Acid: A Logical Lead for Drug Development?

Curr Pharm Des. 2018;24(2):106-122. doi: 10.2174/1381612823666171115094557.

Abstract

Background: Naturally occurring polyphenols are the subject of increasing attention due to their potent antioxidant activity and their marked effects on the prevention of various oxidative stress-associated diseases such as cancer. Ellagic acid (EA) is an herbal polyphenol that is structurally a condensed dimer of gallic acid.

Methods: This review aims to provide a comprehensive and updated overview on the biological activities of EA and potential therapeutic applications.

Results: EA is found in fruits and nuts, either in the combined form with hexahydroxydiphenic acid or in the bound form (ellagitannins). EA exhibits many biological properties such as antioxidant, anti-diabetic, anticancer and apoptosis-inducing activities. These biological and pharmacological properties are relevant to the treatment of several human diseases.

Conclusion: Owing to its multiple mechanisms of action, EA represents a potential therapeutic agent against human diseases particularly cancer.

Keywords: Polyphenol; antioxidant; ellagic acid; gallic acid; pharmacology; phytomedicine..

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / pathology
  • Drug Development
  • Ellagic Acid / pharmacology*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Oxidative Stress / drug effects

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Hypoglycemic Agents
  • Ellagic Acid